Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Beam Therapeutics Inc. Common Stock](/topic/beam-beam-therapeutics-inc)

### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:beam-beam-therapeutics-inc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/beam-beam-therapeutics-inc/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% no change  
**1 Year**: XXX% no change  
**1-Year High**: XXX% on 2025-07-01  
**1-Year Low**: XX% on 2025-09-03  

**Most Supportive Themes**
- **Positive FDA News and Gene-editing Advancements:** (45%) Beam Therapeutics' BEAM-301 IND clearance and RMAT designation for BEAM-101 are driving positive sentiment, with posts highlighting the potential for first-in-class therapies and precise genetic correction.
- **Stock Market Gainers and Mentions in Top Holdings:** (35%) Beam Therapeutics is frequently mentioned as a top gainer, and is included in the top holdings of Cathie Wood's ARK Innovation ETF, indicating strong market interest.
  
**Most Critical Themes**
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %  | Negative | %    |
| ------- | -------- | -  | ------- | -  | -------- | -    |
| X       | XX       | X% | XX      | X% |          |      |
| YouTube | X        | X% |         |    |          |      |
|         |          |    |         |    |          |      |
| Total   | XX       | X% | XX      | X% | X        | NaN% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Beam Therapeutics Inc. Common Stock

Sentiment: XXX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
1 Year: XXX% no change
1-Year High: XXX% on 2025-07-01
1-Year Low: XX% on 2025-09-03

Most Supportive Themes

  • Positive FDA News and Gene-editing Advancements: (45%) Beam Therapeutics' BEAM-301 IND clearance and RMAT designation for BEAM-101 are driving positive sentiment, with posts highlighting the potential for first-in-class therapies and precise genetic correction.
  • Stock Market Gainers and Mentions in Top Holdings: (35%) Beam Therapeutics is frequently mentioned as a top gainer, and is included in the top holdings of Cathie Wood's ARK Innovation ETF, indicating strong market interest.

Most Critical Themes

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XX X% XX X%
YouTube X X%
Total XX X% XX X% X NaN%
Beam Therapeutics Inc. Common Stock (BEAM) Sentiment
/topic/beam-beam-therapeutics-inc/sentiment